|
|
|
|
|
Detail |
| hsa-miR-195 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Causal |
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. |
2006 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. |
2006 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Schizophrenia is associated with an increase in cortical microRNA biogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. |
2008 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Identification of novel microRNA targets based on microRNA signatures in bladder cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Causal |
MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|